Provide sustainable solutions for the global seafood growth

Hans Peter Endal – Product Solution

Seacalx - Timeline

2008 : Institute ofMarine Reasearch -CaO againstSea Urchins

2012: Company founded

2009 -Small tank studies and fieldtrials

2011: Patent protection filed

2012 – Franzefoss Minerals became a shareholder

2013: NIK II bought BTO´sshares and becomes thelargest shareholder

2015 – 2017: In-vivo and In-vitro trials

2017 - Full time researcher at SLRC

Ongoing: Clinicalstudies

Today: Seacalxoperates as an R&D company with 8 FTE

Pål Haldorsen

CEO

Veterinarian and MBA in Strategic Management

Mathias Fossum

Finance Manager

MSc in Economics and Business Administration

Fride Iversen

Quality Manager

M.Sc in Pharmacy

Siri Secher Myrmel

Project Development Manager

M.Sc in Biotechnology

Ingrid Tyssen Bruu

Business Development Manager

M.Sc in Food Science and M.Sc in Nutrition

Linda K. Pedersen

R&D Manager

M.Sc in Chemistry

Hans Peter Endal

Product Solution Manager

M.Sc in Aquaculture

Rune Stigum OisenMarketing DirectorM.Sc in Aquaculture

Management - a strong and multidisciplinary team

Seacalx – our first 2 products

Qlice

Procalx

• Particulate calcium oxide to combat sealice in the Salmon industry

• To be an approved medicine to treat sea lice infection

• Seacalx are performing clinical trials (large scale in field) this year. So far we have used close

to 50.000 kg of our product in these trials

• Particulate calcium oxide to prevent sealice in the Salmon industry

• To be an approved biocide to prevent sealice infection

• Seacalx have permission and are slowly introducing this product to the market this year. So

far we have sold 27.000 kg of this product

Product and target organism I

Product Target organism

Large and rapidly growing market

ANNUAL COSTS RELATED TO SEA LICE, GLOBALLY (BNOK) DISTRIBUTION OF COSTS RELATED TO SEA LICE

Total costs related to sea lice exceeds BNOK 10 globally in 2017. Treatments (BNOK 3,9) and lost growth (BNOK 5) representants the largest costs.

4,8

7,8

10,010,3

2014 2015 2016 2017

Control

Net Cleaning

Treatments

Loss/Mortality

Lost growth/starvation

The Seacalx method: competive advantage

Starvation/Lost growth

Mortality

Fish handling and welfare

Operation

Resistance

Environment

SEACALX METHOD

R&D

Tested on Effect?

Spermatophore Affected (as yet unknown consequences)

Egg strings Affected

Hatching success Moderate to good efficacy

Survival after hatching Moderate to good efficacy

Nauplie’s High efficacy

Copepoditt’s High efficacy

Fastsittende Varying from none to good efficacy

Bevegelige Varying from none to good efficacy

R&D from the past 10 years have led to the following knowledge on our

products effect on sea lice:

Opportunities

• The market for Salmon is continually growing

• The ability to control sea lice is a prerequisite for growth

• Seacalx have good relationship to major players

• We deliver our products through suitable and reasonable priced equipment

• Market entrance is finally a fact and it has already started!

Our solution

R&DSeacalx cooperates with best in a variety of fields